Through its Centers for Therapeutic Innovation (CTI), Pfizer has entered into a drug discovery and development collaboration with the University of California, San Diego (UCSD) Health Sciences that is potentially worth as much as US$50 M over the next 5 years. Dedicated laboratory space will be provided for scientists from Pfizer and UCSD Health Sciences at Pfizer’s La Jolla, California research and development campus and research will focus on the development of biotherapeutics in the areas of neuroscience, cancer, inflammation, metabolism, HIV, pain and clinical pharmacology.